The Emmes team is heading to the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. We’re looking forward to connecting with sponsors, partners, and industry leaders to discuss the future of oncology clinical research and innovation. If you’ll be there, let’s connect. #ASCO2026 #Oncology #ClinicalResearch Don Vena Gina Simone Luca I. Karen Stablein
About us
For over 40 years, our team of 1,000+ experienced professionals have provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. With offices throughout the US, Europe, Canada, and India, Emmes supports the advancement of global public health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making, and operational excellence. Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience. From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations. As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies. Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives. Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.
- Website
-
http://www.emmes.com
External link for Emmes
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, MD
- Type
- Privately Held
Locations
Employees at Emmes
Updates
-
It was enlightening to join the Huntington Disease Awareness Workshop at IGIB, New Delhi, on behalf of Emmes. The workshop brought together experts to discuss how patient registries, genomics-driven research, and stronger collaboration across academia, healthcare institutions, advocacy groups, and industry can help accelerate rare disease research and improve access to clinical trials in India. An insightful discussion highlighting the importance of collaboration in shaping the future of Huntington’s disease research and patient care. #HuntingtonsDisease #RareDisease #ClinicalTrials #HealthcareInnovation #Emmes
-
-
2 days to go until the Huntington Disease Awareness Workshop at IGIB, New Delhi. Join Emmes, along with Pankaj Dua and Dr Arpit Agarwal. Arpit Agarwal, as industry leaders and researchers come together to discuss the future of rare disease research, diagnostics, patient access, and clinical development in India. 📍 IGIB, New Delhi 📅 May 8, 2026 #RareDiseaseResearch #ClinicalResearch #HuntingtonDisease #Emmes #HealthcareInnovation
-
-
Wrapping up Day 2 at #ARVO2026! It’s been a great couple of days filled with meaningful conversations, new connections, and inspiring perspectives across the ophthalmology community. If you’re here, there’s still time to stop by — we’d love to connect and hear what you’re working on. Booth #8050 Emmes team is on site — come say hello! #ARVO2026 #Emmes #OphthalmologyResearch #ClinicalTrials
-
-
-
-
-
+1
-
-
Excited to have our team live at #ARVO2026 — and we’d love to see you at our booth #8050! Don’t forget to stop by for a Muffins & Coffee Talk with Dr. David Eichenbaum as we dive into what’s really shaping ophthalmology trials today.
2 weeks to #ARVO2026! Join us for an in-booth Muffins & Coffee Talk with Emmes Scientific Advisor, Dr. David Eichenbaum, Director of Research at Retina Vitreous Associates, where we’ll dig into what’s really shaping ophthalmology trials today—from imaging workflows and site readiness to the practical realities that slow studies down. Bring your questions and join the conversation. 📍 Booth #8050 🗓️ May 3 @ 9:00 AM MT #ARVO2026 #ClinicalResearch #Ophthalmology Nilay Shah Anne Hoehn Jennifer Clerie Keith Wolsieffer Sarah Nikles Stephane Marin Laura Romero Lars Bonefeld
-
OCT Europe 2026 is just around the corner! The Emmes team will be joining conversations on the increasing complexity in clinical development and how it shows up in practice—across study execution, data flows, and regulatory expectations. At Emmes, we bring scientific rigor and operational discipline to complex clinical research, helping sponsors reduce fragmentation and execute with greater consistency across global programs. If you’re attending, stop by booth #58 to connect. #OCTEurope #ClinicalTrials #ClinicalOperations Stefano Graziadei Jason Miller
-
-
Countdown to #ARVO2026 is on! The Emmes team will be on-site bringing deep expertise across clinical development, biostatistics, data management, and ophthalmology trial execution. Come meet the team at Booth #8050 to discuss how to reduce friction in ophthalmology trial execution—from design through delivery. And don’t miss our in-booth Muffins & Coffee Talk with Emmes Scientific advisor Dr. David Eichenbaum on May 3 @ 9:00 AM MT. Design. Execute. Optimize. #Ophthalmology #ClinicalTrials #ClinicalResearch #eyecelerator Nilay Shah Michael Massaro Anne Hoehn Jennifer Clerie Keith Wolsieffer Sarah Nikles Stephane Marin Laura Romero Lars Bonefeld
-
-
Emmes is proud to be part of the Huntington Disease Awareness Workshop in New Delhi on May 8 at IGIB. Our colleagues Pankaj Dua and Dr Arpit Agarwal will be attending, with Arpit joining a key panel on Rare Disease Research in India—covering access, diagnostics, and the future of clinical trials. As conversations around rare diseases gain momentum, we remain committed to advancing patient-centric research and enabling faster, more inclusive clinical development. #Emmes #RareDiseases #ClinicalResearch #HuntingtonsDisease #IndiaHealthcare
-
-
#ARVO2026 and #Eyecelerator are just days away, and the conversation continues. In this second preview, Emmes Scientific Advisor Dr. David Eichenbaum highlights the real-world pressures shaping ophthalmology trials today—from imaging variability to the operational demands on sites during startup and execution. At Emmes, these are the real-world challenges we’re hearing from sponsors and sites alike and the ones we’re bringing to the forefront at ARVO. Join us for a practical, peer-level discussion at our Muffins & Coffee Talk: 📍 Booth #8050 🗓️ May 3 @ 9:00 AM MT #ARVO2026 #ClinicalResearch #Ophthalmology #eyecelerator Nilay Shah Michael Massaro Anne Hoehn
-
2 weeks to #ARVO2026! Join us for an in-booth Muffins & Coffee Talk with Emmes Scientific Advisor, Dr. David Eichenbaum, Director of Research at Retina Vitreous Associates, where we’ll dig into what’s really shaping ophthalmology trials today—from imaging workflows and site readiness to the practical realities that slow studies down. Bring your questions and join the conversation. 📍 Booth #8050 🗓️ May 3 @ 9:00 AM MT #ARVO2026 #ClinicalResearch #Ophthalmology Nilay Shah Anne Hoehn Jennifer Clerie Keith Wolsieffer Sarah Nikles Stephane Marin Laura Romero Lars Bonefeld